273 related articles for article (PubMed ID: 19842033)
21. Axillary reverse mapping (ARM): where to go.
Shao X; Sun B; Shen Y
Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238
[TBL] [Abstract][Full Text] [Related]
22. A new technique that complements sentinel lymph node biopsy: lymph node dissection under the intercostobrachial nerves in early-stage breast cancer.
Li J; Jia S; Zhang W; Zhang Y; Qiu F; Xue J; Gu X
Clin Breast Cancer; 2013 Jun; 13(3):212-8. PubMed ID: 23380290
[TBL] [Abstract][Full Text] [Related]
23. Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy.
Boneti C; Korourian S; Diaz Z; Santiago C; Mumford S; Adkins L; Klimberg VS
Am J Surg; 2009 Oct; 198(4):482-7. PubMed ID: 19800452
[TBL] [Abstract][Full Text] [Related]
24. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
25. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
26. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
27. Axillary reverse mapping using a fluorescence imaging system in breast cancer.
Noguchi M; Noguchi M; Nakano Y; Ohno Y; Kosaka T
J Surg Oncol; 2012 Mar; 105(3):229-34. PubMed ID: 21913193
[TBL] [Abstract][Full Text] [Related]
28. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
[TBL] [Abstract][Full Text] [Related]
29. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
Beek MA; Gobardhan PD; Klompenhouwer EG; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2015 Jan; 41(1):59-63. PubMed ID: 25468747
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
Golshan M; Martin WJ; Dowlatshahi K
Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
[TBL] [Abstract][Full Text] [Related]
31. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer.
Rubio IT; Cebrecos I; Peg V; Esgueva A; Mendoza C; Cortadellas T; Cordoba O; Espinosa-Bravo M; Xercavins J
J Surg Oncol; 2012 Jul; 106(1):89-93. PubMed ID: 22258666
[TBL] [Abstract][Full Text] [Related]
32. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
[TBL] [Abstract][Full Text] [Related]
33. Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema.
Casabona F; Bogliolo S; Ferrero S; Boccardo F; Campisi C
Ann Surg Oncol; 2008 Nov; 15(11):3318-9. PubMed ID: 18709416
[No Abstract] [Full Text] [Related]
34. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
35. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.
Cocilovo C; Boolbol SK; Valdes E; Feldman S
Am J Surg; 2006 Oct; 192(4):478-80. PubMed ID: 16978953
[TBL] [Abstract][Full Text] [Related]
36. Axillary reverse mapping in breast cancer: a Canadian experience.
Kuusk U; Seyednejad N; McKevitt EC; Dingee CK; Wiseman SM
J Surg Oncol; 2014 Dec; 110(7):791-5. PubMed ID: 25053441
[TBL] [Abstract][Full Text] [Related]
37. A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
Yue T; Zhuang D; Zhou P; Zheng L; Fan Z; Zhu J; Hou L; Yu F; Dong X; Xiao L; He Q
Clin Breast Cancer; 2015 Aug; 15(4):301-6. PubMed ID: 25776198
[TBL] [Abstract][Full Text] [Related]
38. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
39. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
40. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
